Literature DB >> 23920011

Exposure to herpes simplex virus, type 1 and reduced cognitive function.

Pramod Thomas1, Triptish Bhatia, Deepak Gauba, Joel Wood, Colleen Long, Konasale Prasad, Faith B Dickerson, Raquel E Gur, Ruben C Gur, Robert H Yolken, Vishwajit L Nimgaonkar, Smita N Deshpande.   

Abstract

Herpes simplex virus, type 1 (HSV-1) causes cold sores, keratitis and rarely, fatal encephalitis. The infection is lifelong, with sensory ganglia serving as reservoirs of latent infection. Recently, exposure to HSV-1 has also been repeatedly associated with reduced cognitive function among healthy individuals without prior encephalitis. Though HSV-1 does not elevate risk for schizophrenia (SZ) per se, exposure is likewise associated with impaired cognitive functions among SZ patients. The range of cognitive changes observed in HSV-1 exposed persons has not been investigated systematically, nor is it known whether interaction between HSV-1 exposure and SZ related factors contributes to the impairment among SZ patients. Persons with or without schizophrenia/schizophreniform disorder (N = 298 total, DSM IV criteria) were assessed for HSV-1 exposure using serum HSV-1 antibody titers. The Penn Computerized Neurocognitive battery was used to assess eight cognitive domains with respect to accuracy and speed. There were no significant case-control differences in HSV-1 exposure. The SZ/schizophreniform disorder cases were significantly impaired in all cognitive domains compared with the controls. HSV-1 exposure was also associated with reduced cognitive function in the entire sample, but the magnitude of the effects and their patterns differed from the SZ related changes. Further, statistically significant interactions between HSV-1 exposure and SZ case status were not detected. HSV-1 exposure does not elevate risk for SZ, but it is associated with reduced function in specific cognitive domains regardless of SZ diagnostic status. An 'epidiagnostic' model for the association is proposed to explain the results.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cognition; HSV-1; Herpes simplex; Memory; Schizophrenia; Virus

Mesh:

Substances:

Year:  2013        PMID: 23920011      PMCID: PMC3809147          DOI: 10.1016/j.jpsychires.2013.07.010

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  37 in total

1.  Progressive gray matter loss and changes in cognitive functioning associated with exposure to herpes simplex virus 1 in schizophrenia: a longitudinal study.

Authors:  Konasale M Prasad; Shaun M Eack; Dhruman Goradia; Krishna M Pancholi; Matcheri S Keshavan; Robert H Yolken; Vishwajit L Nimgaonkar
Journal:  Am J Psychiatry       Date:  2011-06-01       Impact factor: 18.112

2.  Neurocognitive endophenotypes in a multiplex multigenerational family study of schizophrenia.

Authors:  Raquel E Gur; Vishwajit L Nimgaonkar; Laura Almasy; Monica E Calkins; J Daniel Ragland; Michael F Pogue-Geile; Stephen Kanes; John Blangero; Ruben C Gur
Journal:  Am J Psychiatry       Date:  2007-05       Impact factor: 18.112

3.  A Hindi version of the Diagnostic Interview for Genetic Studies.

Authors:  S N Deshpande; M N Mathur; S K Das; T Bhatia; S Sharma; V L Nimgaonkar
Journal:  Schizophr Bull       Date:  1998       Impact factor: 9.306

4.  Persistent infection with neurotropic herpes viruses and cognitive impairment.

Authors:  A M M Watson; K M Prasad; L Klei; J A Wood; R H Yolken; R C Gur; L D Bradford; M E Calkins; J Richard; N Edwards; R M Savage; T B Allen; J Kwentus; J P McEvoy; A B Santos; H W Wiener; R C P Go; R T Perry; H A Nasrallah; R E Gur; B Devlin; V L Nimgaonkar
Journal:  Psychol Med       Date:  2012-09-14       Impact factor: 7.723

5.  Brain morphological changes associated with exposure to HSV1 in first-episode schizophrenia.

Authors:  K M R Prasad; B H Shirts; R H Yolken; M S Keshavan; V L Nimgaonkar
Journal:  Mol Psychiatry       Date:  2006-10-10       Impact factor: 15.992

6.  Performance of commercial enzyme-linked immunosorbent assays for detection of antibodies to Bordetella pertussis.

Authors:  M Riffelmann; K Thiel; J Schmetz; C H Wirsing von Koenig
Journal:  J Clin Microbiol       Date:  2010-10-13       Impact factor: 5.948

Review 7.  Viruses, schizophrenia, and bipolar disorder.

Authors:  R H Yolken; E F Torrey
Journal:  Clin Microbiol Rev       Date:  1995-01       Impact factor: 26.132

8.  Herpes simplex virus genomes in human nervous system tissue analyzed by polymerase chain reaction.

Authors:  J R Baringer; P Pisani
Journal:  Ann Neurol       Date:  1994-12       Impact factor: 10.422

Review 9.  The neurotropic herpes viruses: herpes simplex and varicella-zoster.

Authors:  Israel Steiner; Peter G E Kennedy; Andrew R Pachner
Journal:  Lancet Neurol       Date:  2007-11       Impact factor: 44.182

10.  Infection with herpes simplex virus type 1 is associated with cognitive deficits in bipolar disorder.

Authors:  Faith B Dickerson; John J Boronow; Cassie Stallings; Andrea E Origoni; Sara Cole; Bogdana Krivogorsky; Robert H Yolken
Journal:  Biol Psychiatry       Date:  2004-03-15       Impact factor: 13.382

View more
  13 in total

1.  Immunoglobulin G genotypes and the risk of schizophrenia.

Authors:  Janardan P Pandey; Aryan M Namboodiri; Robert C Elston
Journal:  Hum Genet       Date:  2016-07-08       Impact factor: 4.132

2.  Association of cognitive function and liability to addiction with childhood herpesvirus infections: A prospective cohort study.

Authors:  Michael M Vanyukov; Vishwajit L Nimgaonkar; Levent Kirisci; Galina P Kirillova; Maureen D Reynolds; Konasale Prasad; Ralph E Tarter; Robert H Yolken
Journal:  Dev Psychopathol       Date:  2017-04-19

3.  Development of an abbreviated form of the Penn Line Orientation Test using large samples and computerized adaptive test simulation.

Authors:  Tyler M Moore; J Cobb Scott; Steven P Reise; Allison M Port; Chad T Jackson; Kosha Ruparel; Adam P Savitt; Raquel E Gur; Ruben C Gur
Journal:  Psychol Assess       Date:  2015-03-30

4.  Emotion discrimination in humans: Its association with HSV-1 infection and its improvement with antiviral treatment.

Authors:  Triptish Bhatia; Joel Wood; Satish Iyengar; Sreelatha S Narayanan; Ram Pratap Beniwal; Konasale M Prasad; Kehui Chen; Robert H Yolken; Faith Dickerson; Ruben C Gur; Raquel E Gur; Smita N Deshpande; Vishwajit L Nimgaonkar
Journal:  Schizophr Res       Date:  2017-08-19       Impact factor: 4.939

5.  Infection with Herpes Simplex virus type 1 (HSV-1) and sleep: The dog that did not bark.

Authors:  Kyrillos M Meshreky; Joel Wood; Kodavali V Chowdari; Martica H Hall; Kristine A Wilckens; Robert Yolken; Daniel J Buysse; Vishwajit L Nimgaonkar
Journal:  Psychiatry Res       Date:  2019-07-31       Impact factor: 3.222

6.  A randomised controlled trial of adjunctive yoga and adjunctive physical exercise training for cognitive dysfunction in schizophrenia.

Authors:  Triptish Bhatia; Sati Mazumdar; Joel Wood; Fanyin He; Raquel E Gur; Ruben C Gur; Vishwajit L Nimgaonkar; Smita N Deshpande
Journal:  Acta Neuropsychiatr       Date:  2016-08-12       Impact factor: 3.403

7.  The Association between Infections and General Cognitive Ability in Young Men - A Nationwide Study.

Authors:  Michael Eriksen Benros; Holger Jelling Sørensen; Philip Rising Nielsen; Merete Nordentoft; Preben Bo Mortensen; Liselotte Petersen
Journal:  PLoS One       Date:  2015-05-13       Impact factor: 3.240

8.  Association between exposure to HSV1 and cognitive functioning in a general population of adolescents. The TRAILS study.

Authors:  Iris Jonker; Hans C Klein; Hester E Duivis; Robert H Yolken; Judith G M Rosmalen; Robert A Schoevers
Journal:  PLoS One       Date:  2014-07-01       Impact factor: 3.240

9.  Different presence of Chlamydia pneumoniae, herpes simplex virus type 1, human herpes virus 6, and Toxoplasma gondii in schizophrenia: meta-analysis and analytical study.

Authors:  José Gutiérrez-Fernández; Juan de Dios Luna Del Castillo; Sara Mañanes-González; José Antonio Carrillo-Ávila; Blanca Gutiérrez; Jorge A Cervilla; Antonio Sorlózano-Puerto
Journal:  Neuropsychiatr Dis Treat       Date:  2015-03-27       Impact factor: 2.570

10.  CX3CR1+ monocytes modulate learning and learning-dependent dendritic spine remodeling via TNF-α.

Authors:  Juan Mauricio Garré; Hernandez Moura Silva; Juan J Lafaille; Guang Yang
Journal:  Nat Med       Date:  2017-05-15       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.